Skip to main content
Clinical Trials/NL-OMON52760
NL-OMON52760
Recruiting
Not Applicable

on-invasive fetal electrocardiography and speckle tracking echocardiography in the second trimester, 16 until 28 weeks gestational age: a prospective cohort study. - NI-fECG and STE: 16-28 weeks gestational age / BEATS-study.

Maxima Medisch Centrum0 sites594 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Zwangerschap: complicaties bij de foetus tijdens de zwangerschap
Sponsor
Maxima Medisch Centrum
Enrollment
594
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Maxima Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • \- Pregnant women with a singleton pregnancy;
  • \- Uncomplicated pregnancy at the time of inclusion;
  • \- Gestational age \<16\+0 weeks;
  • \- Oral and written consent is obtained;
  • \- Maternal age \>\= 18 years.

Exclusion Criteria

  • \- Multiple pregnancies;
  • \- Pre\-existing maternal disease that might influence fetal development (e.g.
  • diabetes mellitus, pre\-existent hypertensive disease or auto\-immune disease);
  • \- Abnormalities found at the structural ultrasound examination (SEO) that might
  • possibly influence fetal cardiac function (e.g. fetal cardiac arrhythmias or
  • congenital abnormalities);
  • \- Contra\-indications to abdominal patch placement (e.g. dermatologic diseases
  • of the abdomen precluding preparation of the abdomen with abrasive paper);
  • \- Women connected to an external or implanted electrical stimulator (e.g. a
  • pacemaker);

Outcomes

Primary Outcomes

Not specified

Similar Trials